...
首页> 外文期刊>European Heart Journal - Case Reports >Simultaneous transfemoral valve-in-valve transcatheter aortic valve replacement and debranching thoracic endovascular aortic repair through a tortuous and shaggy aorta: a case report
【24h】

Simultaneous transfemoral valve-in-valve transcatheter aortic valve replacement and debranching thoracic endovascular aortic repair through a tortuous and shaggy aorta: a case report

机译:通过曲折和毛茸茸的主动脉进行同时变熔阀内经触控管主动脉瓣膜置换和胸腔内血管内血管内主动脉修复:案例报告

获取原文

摘要

Background Transcatheter aortic valve replacement (TAVR) is a viable treatment option for managing aortic prosthetic valve dysfunction. Although the transfemoral approach is the most commonly used and preferred treatment strategy for TAVR, complex vascular access, such as aortic aneurysm, severe tortuosity, and shaggy aorta, is challenging. Case summary An 87-year-old man, who underwent surgical aortic valve replacement for aortic stenosis using a 21-mm Carpentier-Edwards Perimount Valve, presented with New York Heart Association functional Class III dyspnoea. He was diagnosed as having severe symptomatic structural valve deterioration of a bioprosthetic aortic valve. Computed tomography revealed a tortuous and shaggy descending aorta with a saccular aneurysm in the aortic arch. Simultaneous transfemoral valve-in-valve TAVR and Zone 2 thoracic endovascular aortic repair (TEVAR) with debranching were successfully performed using a 22-Fr 65-cm sheath. Although the patient developed paraplegia due to transient spinal cord ischaemia associated with TEVAR, he fully recovered with vasopressor therapy. Discussion To the best of our knowledge, this is the first report on simultaneous successful ‘valve-in-valve’ TAVR and debranching TEVAR using the transfemoral approach. This case demonstrated the feasibility of single-stage transfemoral TAVR and TEVAR in a high-risk patient with multicomponent disease.
机译:背景技术经导管主动脉瓣置换(TAVR)是管理主动脉假体瓣膜功能障碍的可行的治疗选择。虽然经违规方法是TAVR最常用和优选的治疗策略,但复杂的血管进入,如主动脉瘤,严重的曲折和毛茸茸的主动脉,是挑战性的。案例摘要一名87岁男子,使用21毫米木刻 - 爱德华州瓣膜进行手术主动脉瓣膜替代主动脉狭窄,纽约心脏协会功能型III呼吸困难患者。他被诊断出患有严重的症状结构阀的生物假性主动脉瓣劣化。计算机断层扫描揭示了一个曲折和毛茸茸的下降主动脉,在主动脉弓中囊动脉瘤。使用22-FR 65cm护套成功地进行了同时传输阀内TAVR和带有脱鸟的胸腔内血管血管主动脉修复(TEVAR)。虽然患者因与TEVAR相关的短暂脊髓缺血而产生截瘫,但他完全恢复了血管加压菌治疗。据我们所知,这是一份关于同时成功的“阀门内”TAVR和使用经违规方法的船锚TAVAR的第一份报告。本例证明,具有多组分疾病的高风险患者中单阶段转发TAVR和TEVAR的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号